Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Lisa Ensign"'
Autor:
Lisa Ensign, Peter Stokman, Peter G Stokman, Monika Mörsch, Dirk Langeneckhardt, Bradley Bitzer, Sami Boussetta, Valérie Cassan, Annemarie Voortman, Richard Kwock, Philip Beineke, Gernot Hochgräber, Sven Vogelgesang, Diego Herrera, Kristin Nuyens
Publikováno v:
Journal of the Society for Clinical Data Management. 1
INTRODUCTION: The essence of Risk-based Quality Management is to focus on what matters most. Sponsor companies are annually spending many billions of dollars on automated and manual data cleaning, utilizing internal and site resources to create the i
Autor:
Jingshu Liu, G. Caleb Alexander, Ron G. Katriel, Sheila Diamond, Emelly Rusli, Elizabeth B. Lamont, Lisa Ensign
Publikováno v:
JAMA Netw Open
JAMA Network Open
JAMA Network Open
This cohort study evaluates the association of the coronavirus disease 2019 (COVID-19) pandemic with clinical research and development for cancer by studying the initiation of oncology clinical trials over time.
Autor:
Lisa Ensign, Mona A Kelkar, Aaron Galaznik, Emelly Rusli, Lihong Diao, Mark F. Watson, Cynthia Liu
Publikováno v:
Blood. 136:9-9
Background: Past studies have indicated a potential racial disparity in Multiple Myeloma (MM) survival between black and white patients (Costa et al., 2017; Marinac et al., 2020), an issue compounded by minority underrepresentation in clinical trials
Autor:
Ron G. Katriel, Caleb Alexander, Sheila Diamond, Lisa Ensign, Elizabeth B. Lamont, Jingshu Lui
Publikováno v:
Clinical Cancer Research. 26:PO-088
Objective: The COVID-19 pandemic has caused global economic and social upheaval, including in the health care marketplace, yet its impact on clinical research and development has not been well described. We explored the effect of the pandemic on the
Autor:
Janna Andrews, Aaron Galaznik, Kevin Holcomb, Nicole Pollard, Lisa A. Newman, Mark Layton Watson, Lisa Ensign, Bryant Fields, Sheila Diamond
Publikováno v:
Journal of Clinical Oncology. 38:e13102-e13102
e13102 Background: Previous studies have shown a lower survival rate in Black women with breast cancer compared with other ethnic groups, largely explained by the increased incidence of triple negative breast cancer (TNBC). In this study we further e